Cite

HARVARD Citation

    Wang, Y. et al. (n.d.). Targeting Bruton's tyrosine kinase with ibrutinib in B‐cell malignancies. Clinical pharmacology & therapeutics. 97 (5), pp. 455-468. [Online]. 
  
Back to record